Home / Stocks / APGE

APGE insider trading

Apogee Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
1
Bought · 24 mo
$991k
Buys · last 90 days
0 · $0
Most recent buy
2024-12-16

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-10HENDERSON MICHAEL THOMAS
Chief Executive Officer
Sold20,000$133.63$2.7M
2026-06-24Dambkowski Carl
Chief Medical Officer
Sold26,400$132.60$3.5M
2026-06-24HENDERSON MICHAEL THOMAS
Chief Executive Officer
Sold80,000$132.54$10.6M
2026-05-15HENDERSON MICHAEL THOMAS
Chief Executive Officer
Sold18,659$82.05$1.5M
2026-04-10HENDERSON MICHAEL THOMAS
Chief Executive Officer
Sold17,800$82.48$1.5M
2026-01-22Fairmount Funds Management LLC
Director
Sold1,750,000$76.30$133.5M
2026-01-09Dambkowski Carl
Chief Medical Officer
Sold14,820$77.90$1.2M
2025-12-05HENDERSON MICHAEL THOMAS
Chief Executive Officer
Sold40,000$75.01$3.0M
2024-12-16McKenna Mark C.
Director
Bought20,000$49.54$991k
2024-10-04HENDERSON MICHAEL THOMAS
Chief Executive Officer
Sold30,288$56.07$1.7M
2024-09-06HENDERSON MICHAEL THOMAS
Chief Executive Officer
Sold25,641$47.28$1.2M

Most active insider buyers

InsiderRoleBuysTotal bought
McKenna Mark C.Director1$991k

See APGE on the chart

Every insider buy and sell for APGE plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.